Venus Medtech International

Venus Medtech International company information, Employees & Contact Information

Venus Medtech is a prominent player in transcatheter technologies for structural heart disease therapies. Our comprehensive solutions treat all four heart valves within the human heart (TAVR, TPVR, TMVR, TTVR) in addition to hypertrophic cardiomyopathy, hypertensive renal denervation therapy. Founded in 2009 and headquartered in Hangzhou National High-Tech Industrial Development Zone (Binjiang), the company successfully listed on the Main Board of the Hong Kong Stock Exchange (stock code: 2500.HK) in December 2019. Our journey began with the launch of our first product in 2014, under the New Bioprosthetic Aortic Valve Project in China. We followed this with the introduction of the VenusP-Valve in Europe in 2022. We partner with the top physicians across every continent to understand their challenges and identify opportunities. These insights drive novel breakthrough solutions for a better tomorrow. We invest more than $200M in R&D every year, operate in more than 650 centers worldwide, hold a portfolio of more than 800 patents, and boast a track record of more than 13,000 real-world implantations. As a global leader in the making, Venus Medtech's strategic focus is and will always remain to pioneer innovative technology and equip physicians with the tools they need to enhance the quality of life for patients worldwide.

Company Details

Employees
51
Address
Kraijenhoffstraat 137, Amsterdam,north Holland 1018rg,netherlands
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Amsterdam, North Holland
Looking for a particular Venus Medtech International employee's phone or email?

Venus Medtech International Questions

News

Technology Incubator Peregrine Ventures Exits Transcatheter Valve Company Cardiovalve - Diagnostic and Interventional Cardiology

Technology Incubator Peregrine Ventures Exits Transcatheter Valve Company Cardiovalve Diagnostic and Interventional Cardiology

Cardiovalve wins FDA breakthrough nod for tricuspid valve replacement technique - BioWorld MedTech

Cardiovalve wins FDA breakthrough nod for tricuspid valve replacement technique BioWorld MedTech

Top Venus Medtech International Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant